[
    [
        {
            "time": "",
            "orginal_text": "康泰转2：新品竟上 疫苗待放",
            "features": {
                "keywords": [
                    "康泰",
                    "疫苗",
                    "新品"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "康泰转2：新品竟上 疫苗待放",
            "scores": {
                "News_content": "康泰转2：新品竟上 疫苗待放",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "康华生物上半年净利预计增幅超4成 200万支新产能投产将利好下半年",
            "features": {
                "keywords": [
                    "康华生物",
                    "净利",
                    "增幅",
                    "新产能",
                    "投产"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "康华生物上半年净利预计增幅超4成 200万支新产能投产将利好下半年",
            "scores": {
                "News_content": "康华生物上半年净利预计增幅超4成 200万支新产能投产将利好下半年",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "干货！2021年中国用人疫苗行业龙头对比：智飞生物、沃森生物和康泰生物 谁更胜一筹？",
            "features": {
                "keywords": [
                    "疫苗",
                    "智飞生物",
                    "沃森生物",
                    "康泰生物",
                    "龙头对比"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "干货！2021年中国用人疫苗行业龙头对比：智飞生物、沃森生物和康泰生物 谁更胜一筹？",
            "scores": {
                "News_content": "干货！2021年中国用人疫苗行业龙头对比：智飞生物、沃森生物和康泰生物 谁更胜一筹？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "粤产新冠疫苗首次在欧洲获批临床 助力“一带一路”国家共抗疫",
            "features": {
                "keywords": [
                    "粤产",
                    "新冠疫苗",
                    "欧洲",
                    "临床",
                    "一带一路"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "国际合作"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "粤产新冠疫苗首次在欧洲获批临床 助力“一带一路”国家共抗疫",
            "scores": {
                "News_content": "粤产新冠疫苗首次在欧洲获批临床 助力“一带一路”国家共抗疫",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]